Rigel Pharmaceuticals, Inc.

NASDAQ:RIGL

Biotechnology

Healthcare
$42.53 -1.86%

-$0.62 today

Market cap
$800.84M
Beta
1.18
P/E (TTM)
1.7
EPS (TTM)
$19.78
52W Low $18.14High $52.24

Volume 0.24M

Average 0.36M

Balance Sheet

Inspect the capital base behind the business.

Assets

$513.59M

FY 2025 · Annual

+213.2% YoY

Liabilities

$122.11M

FY 2025 · Annual

-24.0% YoY

Equity

$391.48M

FY 2025 · Annual

+11806.3% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents18.89M24.46M32.79M56.75M40.58M
Short-term Investments106.08M33.75M24.15M20.58M114.38M
Net Receivables15.47M40.32M30.55M41.62M51.76M
Inventory6.62M9.12M5.52M6M11.51M
Other Current Assets08.26M6.26M10.17M21.94M
Total Current Assets154.47M115.9M99.27M135.1M240.17M
Property, Plant & Equipment (Net)11.89M2.79M1.03M338K920K
Goodwill00000
Intangible Assets014.95M13.88M27.1M24.75M
Long-term Investments00000
Tax Assets0000245.85M
Other Non-current Assets974K640K3.06M1.44M1.91M
Total Non-current Assets12.86M18.38M17.96M28.87M273.43M
Total Assets167.33M134.28M117.23M163.98M513.59M
Account Payables3.8M22.51M7.14M3.34M7.19M
Short-term Debt007.23M7.27M30.43M
Tax Payables00000
Deferred Revenue10.51M13.51M17.04M27.8M1.36M
Other Current Liabilities24.2M13.86M12.32M10.14M48.35M
Total Current Liabilities63.55M65.21M53.27M63.3M99.24M
Long-term Debt19.91M39.45M52.37M52.41M22.88M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities52.73M42.26M39.94M44.98M0
Total Non-current Liabilities73.4M82.68M92.6M97.39M22.88M
Total Liabilities136.95M147.9M145.87M160.69M122.11M
Common Stock172K174K17K18K18K
Retained Earnings(1.32B)(1.38B)(1.41B)(1.39B)(1.02B)
Accumulated OCI(102K)(153K)8K10K181K
Other Stockholders Equity00000
Minority Interest00000
Total Equity30.37M(13.62M)(28.64M)3.29M391.48M
Total Debt30.57M41.55M60.58M59.97M53.3M
Net Debt11.68M17.09M27.79M3.22M12.72M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$24.4M
Short-term Investments$122.3M
Receivables$49.9M
Inventory$11.7M
Other Current$25.7M
Total Current Assets$234.0M
PP&E (Net)$785.0K
Intangible Assets$24.2M
Tax Assets$243.3M
Other Non-current$2.4M
Total Non-current Assets$270.6M
Total Assets$504.6M

Analysis

Selected assets total $504.6M for Latest. The largest visible component is Tax Assets at $243.3M, about 48.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 13, 2026
SC 13GSC 13G filingNov 10, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
4Statement of changes in beneficial ownershipSep 3, 2026

How much cash does RIGL have?

Rigel Pharmaceuticals, Inc. (RIGL) reported $40.58M in cash and equivalents in fiscal 2025.

How much debt does RIGL carry?

Rigel Pharmaceuticals, Inc. (RIGL) reported $53.30M of total debt, with net debt of $12.72M.